Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    July 2018
  1. GREGOROWITSCH ML, Verkooijen HM, Houweling A, Fuhler N, et al
    Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients.
    Radiother Oncol. 2018 Jul 19. pii: S0167-8140(18)33385.
    PubMed     Text format     Abstract available


  2. BROUWERS PJAM, van Werkhoven E, Bartelink H, Fourquet A, et al
    Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
    Radiother Oncol. 2018 Jul 3. pii: S0167-8140(18)33335.
    PubMed     Text format     Abstract available


    April 2018
  3. GERNAAT SAM, van Velzen SGM, Koh V, Emaus MJ, et al
    Automatic quantification of calcifications in the coronary arteries and thoracic aorta on radiotherapy planning CT scans of Western and Asian breast cancer patients.
    Radiother Oncol. 2018 Apr 24. pii: S0167-8140(18)30199.
    PubMed     Text format     Abstract available


  4. STRNAD V, Major T, Polgar C, Lotter M, et al
    ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Radiother Oncol. 2018 Apr 21. pii: S0167-8140(18)30197.
    PubMed     Text format     Abstract available


    February 2018
  5. MUNSHI A
    The arrival of axilla conserving therapy (ACT). Is this the second revolution in locoregional management of breast cancer care?
    Radiother Oncol. 2018 Feb 23. pii: S0167-8140(18)30066.
    PubMed     Text format    


    January 2018
  6. MONTEN C, Lievens Y
    Adjuvant breast radiotherapy: How to trade-off cost and effectiveness?
    Radiother Oncol. 2018;126:132-138.
    PubMed     Text format     Abstract available


  7. HAVILAND JS, Mannino M, Griffin C, Porta N, et al
    Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.
    Radiother Oncol. 2018;126:155-162.
    PubMed     Text format     Abstract available


    December 2017
  8. AZNAR MC, Duane FK, Darby SC, Wang Z, et al
    Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.
    Radiother Oncol. 2017 Dec 12. pii: S0167-8140(17)32742.
    PubMed     Text format     Abstract available


    October 2017
  9. ROOS CTG, van den Bogaard VAB, Greuter MJW, Vliegenthart R, et al
    Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?
    Radiother Oncol. 2017 Oct 28. pii: S0167-8140(17)32649.
    PubMed     Text format     Abstract available


  10. CHANG JS, Lee J, Chun M, Shin KH, et al
    Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume.
    Radiother Oncol. 2017 Oct 16. pii: S0167-8140(17)32617.
    PubMed     Text format     Abstract available


    September 2017
  11. HANS S, Cottu P, Kirova YM
    Preliminary results of the association of Palbociclib and radiotherapy in metastatic breast cancer patients.
    Radiother Oncol. 2017 Sep 27. pii: S0167-8140(17)32577.
    PubMed     Text format    


  12. TROVO M, Furlan C, Polesel J, Fiorica F, et al
    Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Radiother Oncol. 2017 Sep 21. pii: S0167-8140(17)32556.
    PubMed     Text format     Abstract available


  13. QI XS, Pajonk F, McCloskey S, Low DA, et al
    Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation.
    Radiother Oncol. 2017;124:455-461.
    PubMed     Text format     Abstract available


  14. COLLIS J, Hill MR, Nicol JR, Paine PJ, et al
    A hierarchical Bayesian approach to calibrating the linear-quadratic model from clonogenic survival assay data.
    Radiother Oncol. 2017;124:541-546.
    PubMed     Text format     Abstract available


  15. JANG BS, Kim IA
    A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
    Radiother Oncol. 2017;124:403-410.
    PubMed     Text format     Abstract available


    August 2017
  16. BROUWERS PJAM, van Loon J, Houben RMA, Paulissen J, et al
    Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow up.
    Radiother Oncol. 2017 Aug 24. pii: S0167-8140(17)32511.
    PubMed     Text format     Abstract available


  17. ARISTEI C, Maranzano E, Lancellotta V, Chirico L, et al
    Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study.
    Radiother Oncol. 2017;124:208-213.
    PubMed     Text format     Abstract available


  18. MIGNOT F, Ajgal Z, Xu H, Geraud A, et al
    Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review.
    Radiother Oncol. 2017;124:190-199.
    PubMed     Text format     Abstract available


  19. BRONSART E, Dureau S, Xu HP, Bazire L, et al
    Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.
    Radiother Oncol. 2017;124:214-219.
    PubMed     Text format     Abstract available


  20. BAUMANN BC, Zeng C, Freedman GM, Verginadis II, et al
    Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?
    Radiother Oncol. 2017;124:204-207.
    PubMed     Text format     Abstract available


  21. DEMOOR-GOLDSCHMIDT C, Supiot S, Oberlin O, Helfre S, et al
    Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort study.
    Radiother Oncol. 2017;124:200-203.
    PubMed     Text format     Abstract available


    July 2017
  22. ARSENE-HENRY A, Fourquet A, Kirova YM
    Evolution of radiation techniques in the treatment of breast cancer (BC) patients: From 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using Helical Tomotherapy (HT): A single-centre experience.
    Radiother Oncol. 2017 Jul 18. pii: S0167-8140(17)32450.
    PubMed     Text format    


  23. MIGUEZ C, Jimenez-Ortega E, Palma BA, Miras H, et al
    Clinical implementation of combined modulated electron and photon beams with conventional MLC for accelerated partial breast irradiation.
    Radiother Oncol. 2017;124:124-129.
    PubMed     Text format     Abstract available


    May 2017
  24. KLEMENT RJ, Guckenberger M, Alheid H, Allgauer M, et al
    Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
    Radiother Oncol. 2017;123:227-233.
    PubMed     Text format     Abstract available


    April 2017
  25. VERMA V, Iftekaruddin Z, Badar N, Hartsell W, et al
    Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer.
    Radiother Oncol. 2017 Apr 27. pii: S0167-8140(17)30147.
    PubMed     Text format     Abstract available


  26. BEST L, de Metz C, Olivotto IA, Roy I, et al
    Radiation therapy quality indicators for invasive breast cancer.
    Radiother Oncol. 2017 Apr 10. pii: S0167-8140(17)30133.
    PubMed     Text format     Abstract available


  27. CHESNEY TR, Yin JX, Rajaee N, Tricco AC, et al
    Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis.
    Radiother Oncol. 2017;123:1-9.
    PubMed     Text format     Abstract available


    March 2017
  28. REHAMMAR JC, Jensen MB, McGale P, Lorenzen EL, et al
    Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.
    Radiother Oncol. 2017 Mar 29. pii: S0167-8140(17)30108.
    PubMed     Text format     Abstract available


  29. FRANCOLINI G, Thomsen MS, Yates ES, Kirkove C, et al
    Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1.
    Radiother Oncol. 2017 Mar 25. pii: S0167-8140(17)30107.
    PubMed     Text format     Abstract available


  30. DUANE F, Aznar MC, Bartlett F, Cutter DJ, et al
    A cardiac contouring atlas for radiotherapy.
    Radiother Oncol. 2017;122:416-422.
    PubMed     Text format     Abstract available


  31. LIPPS DB, Sachdev S, Strauss JB
    Quantifying radiation dose delivered to individual shoulder muscles during breast radiotherapy.
    Radiother Oncol. 2017;122:431-436.
    PubMed     Text format     Abstract available


    February 2017
  32. YOON HI, Yoon J, Chung Y, Nam CM, et al
    Individual case review in a phase 3 randomized trial to investigate the role of internal mammary lymph node irradiation for breast cancer: Korean Radiation Oncology Group 08-06 study.
    Radiother Oncol. 2017 Feb 21. pii: S0167-8140(17)30045.
    PubMed     Text format     Abstract available


  33. PRADES J, Algara M, Espinas JA, Farrus B, et al
    Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study.
    Radiother Oncol. 2017 Feb 21. pii: S0167-8140(17)30039.
    PubMed     Text format     Abstract available


    January 2017
  34. LEE J, Hua KL, Hsu SM, Lin JB, et al
    Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk.
    Radiother Oncol. 2017 Jan 10. pii: S0167-8140(16)34481.
    PubMed     Text format     Abstract available


  35. GENTILINI O, Botteri E, Leonardi MC, Rotmensz N, et al
    Ipsilateral axillary recurrence after breast conservative surgery: The protective effect of whole breast radiotherapy.
    Radiother Oncol. 2017;122:37-44.
    PubMed     Text format     Abstract available


  36. PAELINCK L, Gulyban A, Lakosi F, Vercauteren T, et al
    Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial.
    Radiother Oncol. 2017;122:30-36.
    PubMed     Text format     Abstract available


    November 2016
  37. BARTELINK H
    The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials.
    Radiother Oncol. 2016 Nov 24. pii: S0167-8140(16)34384.
    PubMed     Text format     Abstract available


  38. CHANG JS, Byun HK, Kim JW, Kim KH, et al
    Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume.
    Radiother Oncol. 2016 Nov 9. pii: S0167-8140(16)34358.
    PubMed     Text format     Abstract available


    October 2016
  39. HAMMER C, Maduro JH, Bantema-Joppe EJ, van der Schaaf A, et al
    Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.
    Radiother Oncol. 2016 Oct 25. pii: S0167-8140(16)34342.
    PubMed     Text format     Abstract available


    September 2016
  40. ELDESOKY AR, Yates ES, Nyeng TB, Thomsen MS, et al
    Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
    Radiother Oncol. 2016 Sep 30. pii: S0167-8140(16)34303.
    PubMed     Text format     Abstract available


  41. HAVILAND JS, Bentzen SM, Bliss JM, Yarnold JR, et al
    Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.
    Radiother Oncol. 2016 Sep 22. pii: S0167-8140(16)34291.
    PubMed     Text format     Abstract available


    July 2016
  42. QUERO L, Guillerm S, Taright N, Michaud S, et al
    10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment.
    Radiother Oncol. 2016 Jul 26. pii: S0167-8140(16)31171.
    PubMed     Text format     Abstract available


    June 2016
  43. LAURBERG T, Lyngholm CD, Christiansen P, Alsner J, et al
    Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
    Radiother Oncol. 2016 Jun 8. pii: S0167-8140(16)31109.
    PubMed     Text format     Abstract available


    January 2016
  44. NIGLAS M, McCann C, Keller BM, Makhani N, et al
    A dosimetric study of cardiac dose sparing using the reverse semi-decubitus technique for left breast and internal mammary chain irradiation.
    Radiother Oncol. 2016;118:187-93.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: